Semaglutide works similarly to GLP-1 to: Reduce your desire for food Slows down the speed at which food moves out of your stomach This will decrease your appetite and help you reach your weight loss goals
Clinical studies have shown that GLP-1 medications can effectively promote weight loss in patients who do not have diabetes
Stacking MOTS-C: Complementary Protocols and Synergistic Combinations MOTS-c does not operate in isolation in a sophisticated longevity protocol, and understanding which combinations are mechanistically justified versus speculative is important for responsible prescribing
Clinical Results and Safety Phase 2 clinical trials have reported encouraging weight loss outcomes, with participants receiving the highest doses achieving an average body weight reduction of approximately 24% over 48 weeks
2025;10:7 Beller A, Kruglov A, Durek P, von Goetze V, Werner K, Heinz GA, et al
A., Alameda, J